Notice: Check the Website for Longer Posts this Week

I have been working on a series of posts about Fluvoxamine that have become more lengthy than I had expected, to the point that they are far too long for emails. Substack states that this should lead to a truncated email, but I assume that it depends mostly on the email host (protonmail, gmail, yahoo, etc.)

If you have not seen any Fluvoxamine posts in your email, please check the website as you may not be receiving emails. Also, try and check your spam emails. Apparently there has been an issue in other Substacks where emails have been put into the Spam folder.

As a quick shortcut, here are the two posts out so far:

Modern Discontent
Fluvoxamine: The Little SSRI that Could – Part I
Note: This post has surpassed the email limit and may be truncated to fit the maximum email size. If so, please continue reading this post on the Substack page. Over the past two years, the validation of a viable COVID therapeutic was always based off of the mantra of…
Read more
Modern Discontent
Fluvoxamine- The Little SSRI That Could: Part II
This post has gone over the email limit and may become truncated. If so, please check for the full post at the Substack Page. Just a bit More Information So, I said that I would truncate the information in the prior post, but there’s just a few more things to add that are important for evaluating the nonclinical studies in this post. This will mostly incl…
Read more